Home » Topics » BioWorld Science

BioWorld Science
RSS

Eli Lilly presents AOC3 inhibitors

Sep. 7, 2018

Phase IIa study of Yeliva for cholangiocarcinoma advances to second stage

Sep. 7, 2018

FDA approves Tiglutik oral suspension for the treatment of ALS

Sep. 7, 2018

Chinese researchers disclose Abeta aggregation inhibitors

Sep. 7, 2018

Xenon Pharmaceuticals to develop ezogabine for KCNQ2 epileptic encephalopathy

Sep. 7, 2018

A*STAR identifies new SMYD3 inhibitors for cancer

Sep. 7, 2018

Torrent Pharmaceuticals patents compounds for asthma and COPD

Sep. 7, 2018

Researchers identify FHOD3 as a novel disease-causing gene in hypertrophic cardiomyopathy

Sep. 7, 2018

Combining ACE2 and BNP biomarkers improves risk stratification in patients with aortic stenosis

Sep. 7, 2018

HAS2 gene linked to the pathogenesis of lower extremity varicose veins

Sep. 7, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...